UK Government and UKRI invest £54m to tackle biosecurity threats
7 October 2026
A joint UK government and UKRI investment will help prepare for future epidemics, tackle antimicrobial resistance and accelerate the development of next-generation animal vaccines. Researchers across the UK will tackle some of the most pressing risks facing human, animal, and plant health, working with international research experts. Projects range from improving preparedness for future disease outbreaks to developing mRNA vaccines for livestock and tackling the growing threat of antimicrobial resistance (AMR). Scale of the threat
The scale of these threats is already clear. Around one in six laboratory-confirmed bacterial infections worldwide were resistant to antibiotics in 2023, while ash dieback alone is estimated to cost Britain around £15 billion. Invasive mosquitoes also pose a growing threat, with mosquito-borne diseases including dengue, Zika and chikungunya costing at least $94.7 billion globally between 1975 and 2020. A coalition of UK government partners is investing more than £54 million through 18 new research and innovation projects. This public investment is coordinated through UK Research and Innovation (UKRI), with co-funding from partners including the Department for Environment, Food and Rural Affairs (Defra), the Foreign, Commonwealth and Development Office (FCDO), and the Department for Health and Social Care (DHSC). These programmes aim to strengthen our ability to prevent, detect and respond to biological threats affecting people and their livelihoods, wildlife, and ecosystems. Researchers will work with international partners, taking an approach that recognises the links between human, animal and environmental health, and draws on multiple disciplines to tackle complex challenges in a rapidly changing world. Together, the programmes will help build resilience against emerging biosecurity threats, strengthen prevention and response capabilities, enhance food security, and support sustainable economic growth. UKRI Executive Champion for Tackling Infections and BBSRC Executive Chair, Professor Anne Ferguson-Smith, said:
“This investment reflects UKRI’s central role in delivering government priorities and our long-standing commitment to convening and working with partners across government to fund vital One Health research into human, animal, and plant health. “By pooling expertise from across the research and innovation ecosystem in the UK and globally, we can tackle related infectious disease challenges in a more coordinated way to get ahead of emerging biological threats and help protect people, animals, plants and the environment, both in the UK and internationally. Ultimately, it will advance knowledge, improve lives, and drive growth.”
UK Chief Veterinary Officer, Christine Middlemiss, said:
“Investing in cutting-edge research across animal, plant and human health is vital to strengthening our national biosecurity, ensuring we are prepared for future disease threats and able to respond rapidly when they emerge.
“These projects, supported by funding from Defra, will drive innovation in next-generation veterinary vaccines, strengthen epidemic preparedness and help tackle the growing threat of antimicrobial resistance.”
FCDO Chief Scientific Adviser, Professor Sir John Edmunds, said:
“FCDO is pleased to co-fund these innovative research projects. They will make a real difference to understanding and managing emerging diseases and reducing their impact for vulnerable people and their livelihoods, including in humanitarian responses.”
Chief Scientific Adviser at the Department of Health and Social Care (DHSC) and Chief Executive Officer of the FCDO, Professor Lucy Chappell, said:
“In our interconnected world, we must recognise that the health of humans, animals, and the wider environment are inherently linked and interdependent. Similarly, diseases don’t respect borders, and countries must work together to address our greatest health threats. DHSC is pleased to co-fund these important research projects. By taking a One Health approach and bringing together experts from the UK and around the world, we can identify threats earlier, strengthen resilience, and deliver better health outcomes for the public.”
Among the projects:
Professor Kavita Vedhara of Cardiff University will investigate how the interactions between human behaviour, social settings and public trust influence how diseases emerge and spread, helping develop new ways to predict, prevent and prepare for future outbreaks. Professor Jonathan Heeney of the University of Cambridge will use artificial intelligence to create plug-and-play vaccine antigens against animal and zoonotic pathogens, helping accelerate vaccine development for future disease threats. Dr Laura Kelly of Royal Botanic Gardens, Kew will develop new ways to help the UK’s forests and landscapes withstand tree disease epidemics, such as ash dieback, particularly where threats cannot be prevented or eradicated. Professor Francesco Checchi of the London School of Hygiene & Tropical Medicine will develop better ways to assess the risk of disease outbreaks during humanitarian crises, helping organisations anticipate how epidemics could develop and respond more effectively. Professor Simon Graham of The Pirbright Institute will develop next-generation mRNA vaccine platforms for animal health, building technologies that could enable faster responses to emerging livestock diseases and reduce economic impacts on farmers and food producers. Several projects will tackle antimicrobial resistance across food, farming and environmental systems, including reducing inappropriate antibiotic use, addressing airborne fungal resistance and supporting antimicrobial stewardship in agriculture and aquaculture. Respond to future biological threats
The funding will generate new knowledge, tools and technologies that improve the UK’s and international capacity to prevent and respond to future biological threats. The research is expected to support earlier detection of emerging risks, better evidence for policy and decision-making, new approaches to reducing AMR, and faster, more adaptable vaccine and other innovative technologies.
Bringing together expertise from biology, public health, social science, artificial intelligence, environmental research, and veterinary science, the projects will strengthen the UK’s research and innovation ecosystem, build transdisciplinary capabilities and foster partnerships between academia, government, industry and international collaborators.
By investing in capabilities critical to national resilience, the programme will help safeguard health, strengthen food and nutrition security, and protect the natural systems on which people and economies depend.
Source: press release issued by Ukri.